Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Pharma
AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia
AZ licensed a KRAS G12D drug from Usynova. BeiGene bought a CDK2 inhibitor from Ensem. Coherus priced its Chinese PD-1 at a 20% discount to Keytruda.
Angus Liu
Dec 1, 2023 8:34am
The FDA handed down 2 new Forms 483 this week
Nov 30, 2023 10:50am
AZ seeks buyer and contract manufacturer for its Bangalore plant
Nov 17, 2023 11:13am
Aragen commits $30M for its third manufacturing site in India
Oct 30, 2023 3:40pm
Samsung gets stung after FDA flags production lapses in Korea
Oct 20, 2023 10:03am
Flooding halts manufacturing at Alembic Pharmaceuticals plant
Oct 5, 2023 8:45am
